Lunesta Sepracor Inc. - Treatment for InsomniaLunesta is a nonbenzodiazepine hypnotic agent indicated for the treatment of patients who experience difficulty falling asleep as well as for the treatment of patients who are unable to sleep through the night (sleep maintenance difficulty).
Posted: December 2004
- Sepracor Announces FDA Acceptance of Estorra NDA Resubmission and Issuance of Class 2 Review Designation - July 15, 2004
- Sepracor Announces Resubmission of Estorra NDA to FDA - June 16, 2004
- Sepracor Announces Approvable Action for Estorra (eszopiclone) for the Treatment of Insomnia and Provides Update on Launch Plans - March 1, 2004